COVID-19 has changed pharmaceutical companies’ marketing strategies that were based on face-to-face meetings with sales representatives and health professionals.
Transferring business processes to the digital realm implies a new mindset in the companies to place the doctor and the patient at the center of their proposals. Also a new way of thinking about how to add value to the users at each step of their journey.